DekaBank Deutsche Girozentrale’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$662M Hold
3,054,882
1.09% 14
2025
Q4
$541M Hold
3,054,882
0.94% 17
2025
Q3
$681M Hold
3,054,882
1.15% 12
2025
Q2
$561M Sell
3,054,882
-29,149
-0.9% -$5.42M 1% 14
2025
Q1
$625M Buy
3,084,031
+29,149
+1% +$5.67M 1.23% 12
2024
Q4
$542M Hold
3,054,882
1% 14
2024
Q3
$597M Sell
3,054,882
-153,374
-5% -$28.6M 1.11% 13
2024
Q2
$547M Buy
3,208,256
+124,225
+4% +$20.6M 0.98% 14
2024
Q1
$554M Sell
3,084,031
-94,223
-3% -$16.2M 1.03% 15
2023
Q4
$489M Buy
3,178,254
+91,359
+3% +$13.3M 1% 16
2023
Q3
$472M Sell
3,086,895
-29,191
-0.9% -$4.29M 1.09% 16
2023
Q2
$419M Buy
3,116,086
+164,263
+6% +$24.1M 0.94% 18
2023
Q1
$463M Sell
2,951,823
-265,991
-8% -$40.7M 1.17% 12
2022
Q4
$522M Buy
3,217,814
+340,371
+12% +$52.2M 1.38% 9
2022
Q3
$407M Buy
2,877,443
+135,166
+5% +$19.4M 1.2% 11
2022
Q2
$418M Buy
2,742,277
+128,379
+5% +$19.6M 1.22% 12
2022
Q1
$429M Sell
2,613,898
-375,251
-13% -$54.5M 1.05% 14
2021
Q4
$407M Buy
2,989,149
+117,352
+4% +$13.9M 0.99% 14
2021
Q3
$314M Buy
2,871,797
+110,839
+4% +$12.7M 0.88% 17
2021
Q2
$310M Buy
2,760,958
+226,431
+9% +$25.5M 0.9% 15
2021
Q1
$271M Buy
2,534,527
+262,815
+12% +$28.1M 0.9% 17
2020
Q4
$239M Buy
2,271,712
+452,897
+25% +$43.5M 0.9% 19
2020
Q3
$159M Buy
1,818,815
+776,468
+74% +$73.1M 0.7% 29
2020
Q2
$101M Buy
1,042,347
+108,401
+12% +$9.54M 0.64% 38
2020
Q1
$70.3M Buy
933,946
+18,983
+2% +$1.62M 0.54% 47
2019
Q4
$82.2M Sell
914,963
-19,014
-2% -$1.58M 0.5% 44
2019
Q3
$70.2M Buy
933,977
+29,985
+3% +$2.06M 0.44% 54
2019
Q2
$63.8M Buy
903,992
+513,424
+131% +$40.4M 0.32% 83
2019
Q1
$38.3M Sell
390,568
-428,076
-52% -$35M 0.23% 111
2018
Q4
$74.1M Buy
818,644
+428,076
+110% +$37.6M 0.49% 45
2018
Q3
$38.3M Buy
390,568
+17,020
+5% +$1.61M 0.23% 111
2018
Q2
$35.1M Buy
373,548
+30,840
+9% +$3.01M 0.23% 109
2018
Q1
$33M Sell
342,708
-62,891
-16% -$6.91M 0.23% 111
2017
Q4
$29M Hold
405,599
0.23% 112
2017
Q3
$29M Sell
405,599
-2,174
-0.5% -$165K 0.23% 112
2017
Q2
$30M Sell
407,773
-53,995
-12% -$3.63M 0.24% 102
2017
Q1
$30.4M Buy
461,768
+115,550
+33% +$7.26M 0.28% 87
2016
Q4
$21.6M Buy
346,218
+26,006
+8% +$1.59M 0.23% 100
2016
Q3
$20.1M Sell
320,212
-133,759
-29% -$8.66M 0.22% 104
2016
Q2
$28M Sell
453,971
-215,608
-32% -$13.1M 0.32% 77
2016
Q1
$38.1M Sell
669,579
-54,383
-8% -$3.03M 0.45% 51
2015
Q4
$43M Sell
723,962
-137,574
-16% -$7.92M 0.49% 50
2015
Q3
$46.1M Buy
861,536
+55,486
+7% +$3.61M 0.56% 37
2015
Q2
$54.6M Sell
806,050
-115,156
-13% -$7.52M 0.65% 30
2015
Q1
$53.3M Buy
921,206
+189,831
+26% +$11.5M 0.67% 30
2014
Q4
$48.8M Buy
731,375
+38,091
+5% +$2.4M 0.62% 37
2014
Q3
$40.4M Buy
693,284
+127,932
+23% +$7.1M 0.55% 40
2014
Q2
$32M Sell
565,352
-64,693
-10% -$3.39M 0.48% 45
2014
Q1
$32.4M Buy
630,045
+19,465
+3% +$984K 0.51% 39
2013
Q4
$32.2M Buy
610,580
+39,308
+7% +$1.93M 0.53% 41
2013
Q3
$25.6M Sell
571,272
-10,162
-2% -$450K 0.45% 44
2013
Q2
$24.7M Buy
+581,434
New +$25.4M 0.48% 48

Other funds holding ABBV

DekaBank Deutsche Girozentrale's ABBV Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale held its AbbVie (ABBV) position steady in Q1 2026 at 3,054,882 shares worth $662M. The position accounts for 1.09% of the portfolio, ranked #14.

DekaBank Deutsche Girozentrale first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $681M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • DekaBank Deutsche Girozentrale held 3,054,882 shares of AbbVie worth $662M as of Q1 2026.
  • DekaBank Deutsche Girozentrale left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 1.09% of DekaBank Deutsche Girozentrale's portfolio in Q1 2026, its #14 holding.
  • DekaBank Deutsche Girozentrale first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • DekaBank Deutsche Girozentrale's AbbVie position peaked at $681M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.